Latest / Morning Medical with Dr. Chow / Physician Shortage, Birth Outcomes, and Cannabis Effects

Transcript

Physician Shortage, Birth Outcomes, and Cannabis Effects · Morning Medical with Dr. Chow

• 0:00
  Good morning, listeners!
• 0:01
  Welcome to episode two hundred forty-five of Morning Medical with Doctor Chow, your daily
• 0:05
  update on the latest medical and health news from around the world.
• 0:09
  I'm your host, Doctor Chi-Ming Chow.
• 0:12
  As always, we're here to help you stay informed with the latest in health and medicine, so
• 0:17
  let's jump right into today's highlights.
• 0:22
  In today's first segment, we'll be discussing some intriguing insights from medical
• 0:27
  professionals and experts that have surfaced this week.
• 0:31
  Let's start with Doctor Bobby Mukkamala, the president of the American Medical Association.
• 0:37
  He shared an interesting perspective on the ongoing physician shortage, noting that many of
• 0:42
  his colleagues in their late fifties are already contemplating retirement in the next
• 0:46
  five to ten years.
• 0:48
  This highlights a significant challenge in the medical field as we face a potential shortage
• 0:53
  of experienced doctors in the near future.
• 0:57
  Next, we have Arthur Caplan, a distinguished Doctor of Philosophy from NYU Langone Health,
• 1:02
  who shared a rather sobering historical perspective.
• 1:05
  He pointed out that the politicization of healthcare delivery has led to dire
• 1:09
  consequences in the past, referencing regimes like those of the Nazis, Stalin, and Mao
• 1:15
  Zedong.
• 1:15
  His comments were in response to a controversial story suggesting that a Veterans
• 1:20
  Affairs policy might allow medical staff to reject patients based on political party or
• 1:27
  marital status.
• 1:29
  Doctor Bryan Carmody from Eastern Virginia Medical School in Norfolk brought up an
• 1:33
  interesting phenomenon known as "score creep" in medical examinations.
• 1:38
  He likened it to the competitive nature of owning a car better than your neighbor's,
• 1:42
  highlighting how this has led to a higher bar for passing the United States Medical Licensing
• 1:47
  Examination Step 2 clinical knowledge test.
• 1:51
  This underscores the increasing pressure on medical students to excel.
• 1:56
  Doctor Adam Gaffney of Cambridge Health Alliance in Boston discussed the potential
• 2:01
  mortality impacts of recent legislation aimed at cutting Medicaid.
• 2:06
  He emphasized that while the legislation might save money, it primarily benefits tax cuts for
• 2:12
  the wealthy, potentially leading to preventable deaths among those who rely on Medicaid for
• 2:17
  healthcare.
• 2:19
  Doctor Anne Nigra from Columbia University Mailman School of Public Health in New York
• 2:24
  City shared findings on the links between adverse birth outcomes and prenatal exposure to
• 2:29
  arsenic in public water supplies.
• 2:32
  Although the effects may seem small on an individual level, they become quite significant
• 2:36
  when considering the entire population exposed, highlighting the need for vigilance in public
• 2:41
  health policies.
• 2:43
  Doctor Shoshana Marmon from New York Medical College in Valhalla has raised awareness about
• 2:49
  a paradoxical reaction observed in patients receiving dupilumab for atopic dermatitis.
• 2:55
  She noted an increased risk of psoriasis, emphasizing the importance of clinical
• 3:00
  awareness when evaluating new-onset psoriasiform lesions in such patients.
• 3:05
  Lastly, Doctor Emily Brunner from the Hazelden Betty Ford Foundation in Minneapolis discussed
• 3:11
  a new guideline on benzodiazepine tapering.
• 3:15
  She stressed the importance of not just removing a medication, but also carefully
• 3:20
  assessing how it works for each individual and finding ways to support them through the
• 3:24
  process.
• 3:27
  In our next segment, we're diving into exciting findings from a pair of phase three trials that
• 3:32
  were presented at the American Diabetes Association annual meeting.
• 3:36
  These trials explored the effects of combining cagrilintide, a long-acting amylin analogue,
• 3:42
  with semaglutide, a glucagon-like peptide-1 receptor agonist, in adults with obesity, both
• 3:49
  with and without type two diabetes.
• 3:52
  The results were quite remarkable, showing significant weight loss in participants who
• 3:56
  received this combination therapy compared to those who received a placebo.
• 4:02
  In the first trial, known as REDEFINE 1, over three thousand four hundred participants with
• 4:07
  overweight or obesity were involved.
• 4:10
  Those who received the combination of cagrilintide and semaglutide lost an impressive
• 4:15
  twenty-point-four percent of their body weight by week sixty-eight.
• 4:19
  This is compared to just a three percent reduction in the placebo group.
• 4:23
  Doctor W.
• 4:24
  Timothy Garvey from the University of Alabama at Birmingham, who reported these findings,
• 4:29
  noted that this combination therapy provided weight loss in the highest range of efficacy
• 4:35
  observed with existing interventions.
• 4:38
  The second trial, REDEFINE 2, focused on participants with both obesity and type two
• 4:43
  diabetes.
• 4:44
  Here, the combination treatment led to a thirteen-point-seven percent body weight
• 4:48
  reduction from baseline, compared to a three-point-four percent loss with placebo.
• 4:53
  Doctor Melanie Davies from Leicester General Hospital in England highlighted the importance
• 4:58
  of these findings, emphasizing that they represent a significant advancement in
• 5:02
  expanding treatment options for individuals living with both obesity and type two diabetes.
• 5:08
  It's important to note that these results surpassed those seen in previous trials with
• 5:12
  semaglutide alone.
• 5:15
  For instance, in the STEP-1 trial, semaglutide alone resulted in a fourteen-point-nine percent
• 5:21
  weight loss in people with obesity and no diabetes, while the STEP-2 trial showed a
• 5:28
  nine-point-six percent reduction in those with both obesity and type two diabetes.
• 5:34
  This indicates that the addition of cagrilintide significantly boosts weight loss
• 5:39
  outcomes.
• 5:41
  Moreover, the trials revealed that more participants achieved significant milestones in
• 5:46
  weight reduction, with many reaching at least a five, ten, fifteen, or even twenty percent
• 5:52
  weight loss.
• 5:54
  Notably, in the REDEFINE 1 trial, a remarkable nineteen-point-three percent of participants
• 5:59
  without diabetes achieved a body weight reduction of thirty percent or more with the
• 6:04
  combination therapy, compared to just zero-point-four percent with placebo.
• 6:10
  Beyond weight loss, the combination therapy also showed promising results in improving
• 6:15
  glucose control.
• 6:17
  In the REDEFINE 2 trial, seventy-three-point-five percent of
• 6:20
  participants with diabetes achieved an HbA1c of six-point-five percent or less, compared to
• 6:28
  fifteen-point-nine percent in the placebo group.
• 6:31
  This demonstrates the dual benefit of the therapy in managing both weight and blood
• 6:36
  glucose levels.
• 6:38
  Of course, as with any medication, there were some side effects noted.
• 6:42
  The most common were gastrointestinal in nature, including nausea, vomiting, and
• 6:48
  diarrhea.
• 6:49
  However, these were generally mild to moderate and transient.
• 6:54
  It's crucial for clinicians to weigh these potential side effects against the substantial
• 6:58
  benefits of the therapy when considering it for their patients.
• 7:03
  Overall, these trials underscore the potential of cagrilintide and semaglutide as a powerful
• 7:09
  combination for weight management, offering a new avenue for individuals struggling with
• 7:13
  obesity, with or without diabetes.
• 7:17
  As always, it's essential to consult with healthcare providers to determine the best
• 7:21
  treatment plan tailored to individual needs.
• 7:26
  Let's dive into an important topic today: maintaining dental health as we age.
• 7:31
  It's crucial to understand that tooth loss isn't an inevitable part of getting older.
• 7:36
  In fact, dental experts have shared six essential tips to help prevent tooth loss and
• 7:41
  boost overall health in aging adults.
• 7:45
  First and foremost, protecting gum health is vital.
• 7:48
  According to a report by the AARP, around two in three adults over the age of sixty-five are
• 7:55
  dealing with some form of gum disease.
• 7:57
  This condition can lead to serious issues, such as impaired ability to chew hard foods, which
• 8:03
  might put individuals at risk of malnutrition.
• 8:06
  Additionally, untreated gum disease can destroy the bones that hold teeth in place and
• 8:10
  contribute to chronic inflammation, increasing the risk of dementia, heart attack, stroke, and
• 8:17
  even cancer.
• 8:18
  Regular dental checkups and professional cleanings are key to catching gum problems
• 8:22
  early.
• 8:24
  Another important step is to prevent dry mouth.
• 8:28
  Saliva is essential for neutralizing acids and protecting tooth enamel, yet nearly six in ten
• 8:34
  older adults experience dry mouth, often due to medications like antihistamines,
• 8:40
  antidepressants, and blood pressure drugs.
• 8:43
  To combat this, sipping water regularly, rinsing the mouth after eating, and using
• 8:49
  products designed to alleviate dry mouth can be beneficial.
• 8:53
  Personalizing dental visits is also recommended.
• 8:56
  The standard six-month checkup might not be necessary for everyone.
• 9:00
  Some individuals may only need to visit once a year, while others, especially those with
• 9:05
  chronic conditions, might require more frequent visits.
• 9:08
  Evaluating bite position and jaw health can sometimes reveal root causes of chronic
• 9:13
  discomfort, such as headaches and neck pain.
• 9:17
  Financial barriers can also impact dental health.
• 9:20
  With only three in ten adults over sixty-five having dental insurance, many skip necessary
• 9:26
  care.
• 9:28
  Exploring options like dental savings plans, local dental schools, or sliding-scale
• 9:33
  community clinics can provide much-needed support.
• 9:37
  Adopting healthy habits, such as quitting smoking, is another crucial step.
• 9:42
  Smokers are up to three times more likely to lose all their teeth compared to non-smokers.
• 9:48
  Switching to sugar-free gum or candies containing xylitol can help prevent cavities.
• 9:55
  Lastly, restoring the appearance of teeth can revitalize not just your smile but also your
• 10:00
  confidence and overall quality of life.
• 10:04
  Procedures like porcelain veneers can enhance the look and function of your teeth, making a
• 10:09
  significant difference in how you feel about yourself.
• 10:14
  Our final segment for today delves into the complex issue of high-potency cannabis and its
• 10:21
  repercussions on both the healthcare system and legal landscape.
• 10:25
  The narrative around cannabis has evolved dramatically, especially with the rise of
• 10:30
  high-potency products that are far removed from the cannabis of decades past.
• 10:36
  This shift is prompting a reevaluation of its safety and impact at both individual and
• 10:41
  broader societal levels.
• 10:44
  In Canada, particularly Saskatchewan, the healthcare system is grappling with an increase
• 10:48
  in cannabis-related health issues.
• 10:51
  The Saskatchewan Health Authority has reported a steady rise in emergency department visits
• 10:55
  due to cannabis-induced psychosis.
• 10:58
  From 116 cases in 2022, these visits have escalated to 165 in 2024, underscoring the
• 11:06
  growing concern among health professionals.
• 11:10
  Forensic psychiatrist Shabehram Lohrasbe recently testified in a murder trial where
• 11:15
  cannabis's role in inducing psychosis was a focal point.
• 11:19
  The accused, Thomas Hamp, was found to be suffering from severe psychosis at the time of
• 11:24
  the crime, with cannabis use disorder being a significant factor.
• 11:29
  This case highlights the potential for cannabis, particularly in high doses, to
• 11:33
  contribute to acute mental health crises, complicating legal proceedings.
• 11:39
  The potency of cannabis available today, with THC levels reaching up to 30 percent in some
• 11:45
  flower products and even higher in distillates and edibles, is a stark contrast to the
• 11:50
  cannabis of the past.
• 11:51
  Researchers like John Howland and Robert Laprairie from the University of Saskatchewan
• 11:57
  are actively studying the implications of these high-potency products.
• 12:01
  They emphasize that the effects on the brain, particularly in younger users, are still not
• 12:06
  fully understood, making this an area of critical ongoing research.
• 12:10
  Both researchers stress the importance of continued public health research into
• 12:16
  cannabis's effects, advocating for ongoing collaboration with regulatory bodies like
• 12:21
  Health Canada.
• 12:23
  As we navigate this new landscape of cannabis consumption, it's crucial to remain informed
• 12:28
  and cautious, recognizing the significant differences in potency and potential risks
• 12:33
  compared to past use.
• 12:35
  That wraps up today's episode of Morning Medical with Doctor Chow.
• 12:39
  Thank you for joining me as we explored these pressing health topics.
• 12:42
  Stay informed, stay healthy, and I'll see you tomorrow for more insights into the world of
• 12:46
  medicine and healthcare.
• 12:48
  Have a great day!